Target intelligence / Profile preview

Hepatic Enzymes Involved in Toxic Metabolite Formation (N/A)

Target: N/A
Molecular classification: Enzyme, Cytochrome P450, Monooxygenase, Oxidoreductase, Prostaglandin Synthase, Heme protein

Overview

Hepatic enzymes, particularly cytochrome P450s (CYPs) and prostaglandin H2 synthases (PTGS), metabolize drugs and xenobiotics into reactive or toxic metabolites. These metabolites can cause direct cellular injury, oxidative stress, or trigger immune-mediated damage, leading to hepatotoxicity. The activity of these enzymes is influenced by genetic polymorphisms, drug-drug interactions, and physiological states.

Other names: Drug-metabolizing enzymesXenobiotic metabolizing enzymesCYP enzymesCytochrome P450 enzymesPTGS enzymesProstaglandin H2 synthases

Mechanism of action

Oxidative biotransformation of xenobiotics into reactive or toxic metabolites

Biological functions

Xenobiotic metabolismDrug metabolismOxidationDetoxificationBioactivationSteroid hormone synthesisFatty acid metabolismArachidonic acid metabolism

Disease associations

Drug-induced liver injury (DILI)HepatotoxicityAdverse drug reactionsCancer (some isoforms)Inflammation (PTGS)Acetaminophen toxicity

Safety considerations

Drug-drug interactionsGenetic polymorphism effectsInter-individual variabilityHepatotoxicityIdiosyncratic drug reactionsIncreased risk of toxicity in certain patient populations (e.g., those with glutathione depletion)

Interacting drugs

Acetaminophen

3 more in the full profile.

Biomarkers

CYP2E1 activityCYP3A4 activityCYP2D6 activityNAPQI levelsGlutathione levels

Beyond the preview

Go deeper on Hepatic Enzymes Involved in Toxic Metabolite Formation (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatic Enzymes Involved in Toxic Metabolite Formation (N/A).

Explore the full profile